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Abstract Here, we characterized the skin and hair phenotype of
mice lacking the fibroblast growth factor 10 gene (Fgf10), a
newly identified member of the fibroblast growth factor family.
Histological examination of Fgf103=3 newborn mouse skin
revealed abnormalities in epidermal morphogenesis. The number
of proliferating cells in the basal layer was decreased, the
granular layer was hypoplastic and lacked distinctive keratohya-
line granules and tonofibrils. The expression of loricrin, a
marker of epidermal differentiation, was dramatically reduced.
Despite the presence of Fgf10 transcripts in normal hair follicles,
abnormalities of hair development were not observed in Fgf103=3
skin. These data suggest that Fgf10 is required for embryonic
epidermal morphogenesis but is not essential for hair follicle
development. ß 2000 Federation of European Biochemical So-
cieties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
The ¢broblast growth factor (Fgf) family is comprised of
more than 20 structurally related polypeptides that have been
implicated in multiple aspects of vertebrate embryonic devel-
opment and adult tissue homeostasis, including wound heal-
ing and tumorigenesis.
The ¢broblast growth factor 10 gene, Fgf10, originally iden-
ti¢ed based on sequence homology with Fgf3 and Fgf7, is
expressed in several embryonic organs, including lungs, limbs,
posterior pituitary, duodenum and spinal cord [1]. In adult
tissues, Fgf10 transcripts are found in the lung, heart [1]
and the dermal component of mouse skin [2]. The FGF10
protein initiates outgrowth of limb buds [3], and induces
branching morphogenesis of embryonic mouse lung [4]. Two
studies found that Fgf103=3 mice died at birth, primarily due
to defective lung development suggesting that Fgf10 functions
as an essential regulator during organogenesis [5,6].
Among the known Fgf family members, Fgf10 is most sim-
ilar to Fgf7 (keratinocyte growth factor) [7], which is ex-
pressed in the dermis [8] and hair follicles [9]. While an im-
portant role of FGF7 in mediating the initiation and
acceleration of wound healing was suggested [10], Fgf73=3
mice have no obvious cutaneous abnormality [11].
Recently, human Fgf10 was shown to be expressed in the
dermal papilla, outer root sheath cells and epidermal kerati-
nocytes [12]. Recombinant FGF10 protein is mitogenic for
fetal rat keratinizing epidermal cells, but has essentially no
mitogenic activity for established ¢broblasts cell lines such
as NIH/3T3 [13]. Moreover, it has been shown that the in-
duction of Fgf10 expression during wound healing is more
prominent than that of Fgf7 [14]. During skin morphogenesis,
however, the physiological role of Fgf10 remains to be eluci-
dated. In this study, we characterized the skin and hair phe-
notype of mice lacking Fgf10.
2. Materials and methods
2.1. Animals
The Fgf103=3 mice and genotyping have been previously described
[6].
2.2. Histological analysis and immunostaining
Newborn mice were sacri¢ced and 6-Wm-thick sections of the ¢xed
skin, for a total of 10 skin specimens, were stained with hematoxylin/
eosin (HpE). Frozen skin sections from 18.5 days post coitum (dpc)
were stained with optimal dilutions of antibodies against transgluta-
minase 1 (kindly provided by Dr. Takashi Hiiragi [15]), loricrin (Bab-
co, Richmond, CA, USA) and cytokeratin 14 (K14; Cymbus Bio-
science, Southampton, UK). Para⁄n sections of 16.5 dpc embryonic
skins were stained with rabbit anti-mouse FGF10 antibodies (sc-7917,
RpD systems, CA, USA). Proliferating cells were detected using an
anti-proliferating cell nuclear antigen (PCNA) (Dako Japan Co., Ja-
pan).
2.3. In situ hybridization for gene expression
In situ hybridization with digoxigenin-labeled probes was per-
formed as described [16]. The following probes were used: Fgf10
(kindly provided by H. Ohuchi and N. Itoh), Fgf2 (kindly provided
by G. Martin) and Fgf7 (Riken Institute). Sense probes were used as
negative controls.
2.4. Transplantation of full-thickness Fgf103=3 skin grafts onto nude
mice
1.5 cm2 full-thickness skin grafts were isolated from 18.5 dpc fetal
mice and transplanted on adult BALB/c nu/nu mice (Japan SLC).
Subcutaneous tissue was removed from donor trunk skin. Recipient
mice were anesthetized and trunk skin equivalent to the size of the
graft was excised, sparing the panniculus carnosus. Two months after
the transplantation, incisional biopsies were performed under general
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anesthesia. All experimental procedures were undertaken in accor-
dance with the Guideline for Animal Experiment, Faculty of Medi-
cine, Kumamoto University, Japan.
2.5. Electron microscopy
For transmission electron microscopy, the back skin from wild-type
and mutant mice were ¢xed by standard procedures, dehydrated and
embedded in Epon 812. Sections were double-stained with uranyl
acetate and lead citrate, and examined with an Hitachi JEM-100S
electron microscope. For scanning electron microscopy (SEM), hair
specimens were removed from back skin and brie£y washed in phos-
phate-bu¡ered saline before ¢xing in 1% osmium tetroxide in 0.1 M
cacodylate bu¡er. The dried samples were coated with gold, and ex-
amined with an Hitachi S-800 scanning electron microscope.
2.6. Reverse transcription-polymerase chain reaction (RT-PCR)
Total RNA was extracted from wild-type and Fgf103=3 mice back
skin at 18.5 dpc by standard procedures. RT-PCR was carried out
using a One-Step RT-PCR System (Gibco BRL). The following prim-
ers were used (ampli¢ed length shown as bp): Fgf7 5P GTGAGAA-
GACTGTTCTGTCG, Fgf7 3P GCCATAGGAAGAAAATGGGC
(380 bp), Fgf2 5P AACGGCGGCTTCTTCCTGCG, Fgf2 3P GCCC-
AGTTCGTTTCAGTGCC (289 bp), Fgfr2 5P CCAGAAGAGCCAC-
CAACCAAATACC, Fgfr2 3P GACAAACTCCACATCCCCTCCG
(729 bp), Skn-1a (Oct-11) 5P GCTTCTCTCCATCCACTCCAGC,
Skn-1a (Oct-11) 3P CTCACCACCTCCTTCTCCATCG (713bp), Shh
5P GACGGCCATCATTCAGAGGAG, Shh 3P AGGAAGGTGA-
GGAAGTCGCTG (335 bp), PDGF-A 5P GGCTCGAAGTCA-
GATCCACAGC, PDGF-A 3P CCTCTAACCTCACCTGGACCTC
(417 bp), TGF-L2 5P CTTAACATCTCCCACCCAGCGC, TGF-L2
3P GCAGTAGGCAGCATCCAAAGCG (400 bp).
Each primer set £anked at least one intron to discriminate the
contamination with genomic DNA. Primer speci¢city of the PCR
products was con¢rmed by a subsequent nested PCR. EF-1K primers
were used as an internal standard.
3. Results
3.1. Expression of Fgf10 during skin and hair follicle
morphogenesis
Fgf10 transcripts were detected in the basal layer of the
epidermis at 17.5 dpc (Fig. 1B). Correspondingly, FGF10
protein was detected in the epidermis (Fig. 1F). Within hair
follicles, Fgf10 mRNA was detected in the dermal papilla
(Fig. 1D; white arrow) and in the hair matrix (Fig. 1D; white
arrowheads). Dynamic changes of gene expression of several
regulatory factors have been reported during the hair follicle
development. Low level Fgf10 expression was detected in em-
bryonic hair follicles at earlier stages between 16.5 and 18.5
dpc (data not shown). Although it was previously reported
that human Fgf10 is expressed in the dermal papilla and outer
root sheath cells [12], we could not detect its expression in the
developing murine outer root sheath.
3.2. Analysis of the skin from Fgf103=3 newborn mice
Histological examination of Fgf103=3 newborn mouse skin
revealed that the granular layer of the epidermis was thinner
than that of control mice, and granular cells were formed
without distinctive keratohyaline granules (KHGs) and tono-
¢brils (Fig. 2B). Moreover, ultrastructural analysis of the mu-
tant granular layer revealed that the KHGs (Fig. 2C,D; white
arrowheads) were immature and surrounded by loosely
packed tono¢bril bundles (Fig. 2C,D; white arrow). To ana-
lyze the phenotype in more detail, we examined the expres-
sions of two epidermal di¡erentiation markers, loricrin and
transglutaminase 1 (TGase 1). The expression of loricrin
was reduced dramatically in the Fgf103=3 skin (Fig. 2F),
Fig. 1. Expression of Fgf10 during skin and hair follicle morphogen-
esis. In situ hybridization of Fgf10 in 17.5 dpc fetal mouse skin (B)
and hair follicles 11 days after birth (D). An Fgf10-sense probe was
used as a negative control (A and C). Immunohistochemical analysis
of the FGF10 protein in fetal mouse skin tissue sections of wild-
type mice (positive control) (F) and mutant (Fgf103=3) (E). Magni-
¢cations: U400 (A, B, E and F), U200 (C and D). e, epidermis.
Fig. 2. Histological analysis of Fgf103=3 mouse skin. HpE staining
of skin from newborn wild-type (A) and mutant mice (B). Ultra-
structure of the wild-type (C) and mutant mice epidermis (D).
Transverse sections of dosal skin from wild-type (E, G and I) and
mutant fetuses (F, H and J) at 18.5 dpc stained with antibodies to
loricrin (visualization with Texas red) (E and F), TGase 1 (visualiza-
tion with Cy3) (G and H), K14 (visualization with FITC) (E^H)
and PCNA (visualization with 3-amino-9-ethylcarbazol) (I and J).
Magni¢cations: U400 (A and B), U3000 (C and D), U200 (E-J).
b, basal layer of epidermis; s, spinous layer; g, granular layer;
c, corni¢ed layer.
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but TGase 1 was expressed in the upper spinous and granular
layers of both the control and Fgf103=3 skins (Fig. 2G,H).
Similarly, K14 protein was normally expressed in the basal
layer and hair follicles of Fgf103=3 mice (Fig. 2E^H). To
investigate cell proliferation rates, PCNA expression levels
were assessed. A signi¢cant decrease (an average of 20% re-
duction was evaluated by several sections) in the number of
proliferating cells was observed in the basal layer of Fgf103=3
mice (Fig. 2I,J).
3.3. Analysis of hair development in Fgf103=3 derived
full-thickness skin grafts
Because Fgf103=3 mice die soon after birth due to a lack of
lung development, we transplanted fetal skin to athymic nude
mice to study postnatal hair development. While Fgf10 is ex-
pressed in wild-type hair follicles (Fig. 1D), transplanted
Fgf103=3 skin grafts generated abundant pigmented hairs,
comparable to controls. The morphology of hair follicles
from Fgf103=3 mice was indistinguishable from that of con-
trol follicles (Fig. 3A,B), and no major abnormalities were
detected on the surface or inner structure of the hairs exam-
ined by SEM (Fig. 3C,D) and light microscopy (data not
shown).
3.4. Other Fgf transcripts, Fgf7 and Fgf2, were detected in the
Fgf103=3 skin
Fgf103=3 skin showed hypoplastic epidermal morphogene-
sis (Fig. 2), but no prominent abnormality during hair devel-
opment (Fig. 3). Hence, we considered the possibility that
other members of the Fgf family might compensate for the
loss of Fgf10. Among the known Fgf family members, Fgf10
is most similar in sequence and biological properties to Fgf7.
Fgf7 and Fgf2 mRNAs were detected in wild-type hair fol-
licles, as previously described [9,17,18]; Fgf2 and Fgf7 tran-
scripts were expressed in the hair matrix and dermal papilla,
respectively (Fig. 4A). Next, we examined the levels of expres-
sion of Fgf7, Fgf2 and several other important regulators
during skin morphogenesis, including Skn-1a [19], sonic hedge-
hog (Shh) [20,21], TGF-L2 [22] and PDGF-A [23]. mRNA ex-
pression of Fgf7, Fgf2 and other regulators was similar in skin
samples from Fgf103=3 and control mice (Fig. 4B).
4. Discussion
During wound healing, administration of the FGF10 pro-
tein leads to signi¢cant stimulation of epithelial growth and
granulated tissue formation [24], and signi¢cant increase in
wound collagen content [25]. However, the physiological
role of Fgf10 during skin morphogenesis has not been well
established.
FGF10 binds to FGFR2 with an a⁄nity comparable to
that of FGF7. FGFR2 has two receptor isoforms, IIIb and
IIIc. Fgfr2IIIb, which is expressed mainly in the basal layer
and hair follicles of the skin, is important for skin develop-
ment as shown by a recent knockout experiment [26]. Fur-
thermore, overexpression of truncated Fgfr2 has been shown
to induce severe skin abnormalities, including epidermal atro-
phy and hair follicle defects [27]. These results suggest that the
FGFR2 ligands, FGF7 and FGF10, play important roles in
hair and epidermal morphogenesis.
Gene knockout experiments for Fgf family members have
revealed abnormalities in hair development. Fgf53=3 mice
demonstrated an abnormal long hair phenotype [28] and the
hair coat of Fgf73=3 mice has a greasy or matted appearance
Fig. 3. Analysis of Fgf103=3 hair. HpE stained skin sections of
wild-type (A) and mutant mice (B). SEM analysis showing the sur-
face of the hairs of wild-type (C) and mutant mice (D). Magni¢ca-
tions: U400 (A and B), U1500 (C and D). DP, dermal papilla;
HM, hair matrix.
Fig. 4. In situ hybridization of Fgf2 and Fgf7 in wild-type hair fol-
licles (A; magni¢cations: U200). Detection of other Fgf and other
regulatory factor transcripts in Fgf103=3 skin (B). mRNA was iso-
lated from 18.5 dpc fetal mouse dorsal skin and subjected to RT-
PCR as described in Section 2.
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[11]. In this study, Fgf10 transcripts were detected in the der-
mal papilla and the hair matrix in hair follicles (Fig. 1D), but
no abnormalities were found in hair development of Fgf103=3
mice, suggesting that other Fgfs expressed in hair follicles
(Fig. 4B) may have redundant function with Fgf10.
Whereas Fgf7 knockout mice have no prominent abnormal-
ities in epidermal development [11], we demonstrated aberrant
epidermal morphogenesis in Fgf103=3 newborn mice. Presum-
ably, FGFR2 ligands di¡er in their ability to compensate for
each other, thus yielding distinct phenotypes in knockout mice
for the various FGFR2 ligands. Recognizing such possibil-
ities, it was revealed that mRNAs encoding Fgf7 and Fgf2
were present in the skin samples of Fgf103=3 mice in levels
similar to those in controls (Fig. 4B).
KHGs are the most conspicuous organelles in the granular
cells of keratinized epidermis. In rodents, KHGs are com-
posed of F-granules and L-granules. In the present study,
the expression of ¢laggrin mRNA, a major component of
F-granules, was similar in Fgf103=3 and control mice (data
not shown). By contrast, loricrin, which is a major component
of L-granules and coexpressed with ¢laggrin in terminally
di¡erentiating keratinocytes, was reduced dramatically in the
Fgf103=3 skin (Fig. 2F). It is likely that Fgf10 functions dur-
ing L-granule formation, possibly by regulating the expression
of loricrin during di¡erentiation of keratinocytes.
It was recently shown that the inherited skin diseases Voh-
winkel’s syndrome (VS) and progressive symmetric erythro-
keratoderma (PSEK) are caused by loricrin mutations [29].
Although loricrin defects are responsible for such diseases,
the pathoetiologic mechanisms for the altered epidermal dif-
ferentiation remain to be explored. Previously, it was reported
that the expression of FGF7 and its receptor, FGFR2, was
altered in psoriasis [30]. Therefore, it would be intriguing to
examine the functions of Fgf10 in a pathological and molec-
ular cascade underlying such skin diseases.
It was previously suggested that the POU domain factors,
Skn-1a and Oct-6 (Tst-1), might have redundant functions in
epidermal development [19]. Our data suggests that Fgfs may
also carry out redundant function in hair and epidermal de-
velopment. It will be necessary to analyze the possible cross-
regulatory functions of these signaling molecules during skin
development by utilizing double or compound knockout mice
(Fgf compound knockout mice, etc.).
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